Cleared Traditional

K120561 - NEUROBLATE SYSTEM

K120561 is an FDA 510(k) clearance for NEUROBLATE SYSTEM, manufactured by Monteris Medical, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 402-day FDA review.

K120561 · Monteris Medical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
402d
Days
Class 2
Risk

K120561 is an FDA 510(k) clearance for the NEUROBLATE SYSTEM. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Monteris Medical, Inc. (Winnipeg, Mb, CA). The FDA issued a Cleared decision on April 1, 2013 after a review of 402 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Monteris Medical, Inc. devices

FDA 510(k) Submission Details - K120561

510(k) Number K120561 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 24, 2012
Decision Date April 01, 2013
Days to Decision 402 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
287d slower than avg
Panel avg: 115d · This submission: 402d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 2203
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K120561.
PASTELLE Q-SWITCHED ND: YAG LASER
K123293 · Won Technology Co., Ltd. · Apr 2013
MULTILASER SYSTEM
K123777 · Ultralight Laser Technologies, LLC · Apr 2013
EPIC 10S
K130465 · Biolase Technology, Inc. · Apr 2013
VENACURE EVLT NEVERTOUCH PROCEDURE KIT
K130671 · AngioDynamics, Inc. · Mar 2013
FIBERLASE ENDURE CO2 FIBER
K130164 · Lumenis, Ltd. · Mar 2013
DORNIER MEDILAS UROPULSE
K130344 · Dornier Medtech America, Inc. · Mar 2013